ARDT · Insider Trading
Ardent Health, Inc.
Every open-market purchase and sale reported by ARDT officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-29 | Alfred Lumsdaine | Chief Financial Officer | F | −3,389 | −$35.72K |
| 2026-09-29 | David Raynor Byers | SVP & Chief Accounting Officer | F | −524 | −$5.52K |
| 2026-09-29 | Stephen C. Petrovich | EVP, GC and Secretary | F | −788 | −$8.31K |
| 2026-07-02 | Dave Caspers | CEO and President | A | +103,653 | — |
| 2026-06-08 | Alfred Lumsdaine | Chief Financial Officer | Buy | +10,000 | +$88.10K |
| 2026-06-08 | Robert DeMichiei | Director | Buy | +11,260 | +$98.30K |
| 2026-04-02 | Rahul Sen | Director | A | +14,231 | — |
| 2026-04-02 | Peter J. Bulgarelli | Director | A | +14,231 | — |
| 2026-04-02 | Robert Thomas Webb | Director | A | +14,231 | — |
| 2026-04-02 | William M Goodyear | Director | A | +14,231 | — |
| 2026-04-02 | Ellen Havdala | Director | A | +14,231 | — |
| 2026-04-02 | Dave Caspers | Chief Operating Officer | MIXED | +32,989 | −$23.27K |
| 2026-04-02 | Peter C B Bynoe | Director | A | +14,231 | — |
| 2026-04-02 | Suzanne Campion | Director | A | +14,231 | — |
| 2026-04-02 | Alfred Lumsdaine | Chief Financial Officer | MIXED | +46,955 | −$59.47K |
| 2026-04-02 | Robert DeMichiei | Director | A | +14,231 | — |
| 2026-04-02 | David Raynor Byers | SVP & Chief Accounting Officer | MIXED | +9,795 | −$15.02K |
| 2026-04-02 | Mark R Sotir | Director | A | +14,231 | — |
| 2026-04-02 | Edmondo Robinson | Director | A | +14,231 | — |
| 2026-04-02 | Stephen C. Petrovich | EVP, GC and Secretary | MIXED | +21,671 | −$27.87K |
| 2026-04-02 | Martin Bonick | President and CEO | MIXED | +115,637 | −$163.66K |
| 2026-03-13 | Ethan Chernin | President of Health Services | A | +32,408 | — |
| 2026-03-13 | Martin Bonick | President and CEO | A | +195,316 | — |
| 2026-03-13 | David Raynor Byers | SVP & Chief Accounting Officer | A | +8,859 | — |
| 2026-03-13 | Alfred Lumsdaine | Chief Financial Officer | A | +61,081 | — |
| 2026-03-13 | Stephen C. Petrovich | EVP, GC and Secretary | A | +34,733 | — |
| 2025-09-30 | David Raynor Byers | SVP & Chief Accounting Officer | F | −524 | −$6.91K |
| 2025-09-30 | Alfred Lumsdaine | Chief Financial Officer | F | −3,389 | −$44.70K |
| 2025-09-30 | Stephen C. Petrovich | EVP, GC and Asst. Secretary | F | −788 | −$10.39K |
| 2025-04-04 | Robert DeMichiei | Director | A | +10,073 | — |
| 2025-04-02 | David Schultz | President Hospital Operations | MIXED | +25,160 | −$25.09K |
| 2025-04-02 | Stephen C. Petrovich | EVP, GC and Asst. Secretary | MIXED | +20,835 | −$19.64K |
| 2025-04-02 | Alfred Lumsdaine | Chief Financial Officer | MIXED | +51,461 | −$34.51K |
| 2025-04-02 | Ethan Chernin | President of Health Services | MIXED | +19,582 | −$18.32K |
| 2025-04-02 | Martin Bonick | President and CEO | MIXED | +121,957 | −$178.34K |
| 2025-04-02 | David Raynor Byers | SVP & Chief Accounting Officer | MIXED | +10,889 | −$9.29K |
| 2025-04-02 | Dave Caspers | Chief Operating Officer | MIXED | +38,288 | −$32.17K |
| 2025-03-25 | Ellen Havdala | Director | A | +12,916 | — |
| 2025-03-25 | William M Goodyear | Director | A | +12,916 | — |
| 2025-03-25 | Edmondo Robinson | Director | A | +12,916 | — |
| 2025-03-25 | Peter C B Bynoe | Director | A | +12,916 | — |
| 2025-03-25 | Suzanne Campion | Director | A | +12,916 | — |
| 2025-03-25 | Robert Thomas Webb | Director | A | +12,916 | — |
| 2025-03-25 | Rahul Sen | Director | A | +12,916 | — |
| 2025-03-25 | Mark R Sotir | Director | A | +12,916 | — |
| 2024-12-16 | Suzanne Campion | Director | A | +10,793 | — |
| 2024-12-16 | Robert Thomas Webb | Director | A | +10,793 | — |
| 2024-12-16 | Edmondo Robinson | Director | A | +10,793 | — |
| 2024-12-16 | Peter C B Bynoe | Director | A | +10,793 | — |
| 2024-12-16 | William M Goodyear | Director | A | +10,793 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Martin Bonick | President and CEO | 1,437,937 | $17.51M |
| Stephen C. Petrovich | EVP, GC and Secretary | 960,144 | $11.69M |
| Alfred Lumsdaine | Chief Financial Officer | 325,794 | $3.97M |
| Dave Caspers | CEO and President | 174,930 | $2.13M |
| David Raynor Byers | SVP & Chief Accounting Officer | 129,921 | $1.58M |
| Peter C B Bynoe | Director | 115,367 | $1.41M |
| Ellen Havdala | Director | 115,367 | $1.41M |
| William M Goodyear | Director | 115,367 | $1.41M |
| Robert Thomas Webb | Director | 78,215 | $952.66K |
| Ethan Chernin | President of Health Services | 68,396 | $833.06K |
| Edmondo Robinson | Director | 58,215 | $709.06K |
| Suzanne Campion | Director | 58,215 | $709.06K |
| Rahul Sen | Director | 38,709 | $471.48K |
| Mark R Sotir | Director | 38,709 | $471.48K |
| David Schultz | President Hospital Operations | 37,187 | $452.94K |
| Robert DeMichiei | Director | 35,564 | $433.17K |
| Peter J. Bulgarelli | Director | 14,231 | $173.33K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ARDT quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.